• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Issues in contemporary fluid management.当代液体管理中的问题
Crit Care. 2000;4 Suppl 2(Suppl 2):S1-2. doi: 10.1186/cc964. Epub 2000 Oct 13.
2
Pathophysiology of fluid imbalance.液体平衡失调的病理生理学
Crit Care. 2000;4 Suppl 2(Suppl 2):S3-7. doi: 10.1186/cc968. Epub 2000 Oct 13.
3
Albumin and artificial colloids in fluid management: where does the clinical evidence of their utility stand?白蛋白和人工胶体在液体管理中的应用:其效用的临床证据处于何种状况?
Crit Care. 2000;4 Suppl 2(Suppl 2):S16-20. doi: 10.1186/cc965. Epub 2000 Oct 13.
4
Fluid therapy and the resuscitation of traumatic shock.液体疗法与创伤性休克的复苏
Crit Care Clin. 1990 Jan;6(1):61-72.
5
Fluid balance.液体平衡
Vox Sang. 2004 Jul;87 Suppl1:77-81. doi: 10.1111/j.1741-6892.2004.00436.x.
6
Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia.晶体或胶体液负荷与脓毒症和非脓毒症低血容量重症患者的肺通透性、水肿及损伤
Crit Care Med. 2009 Apr;37(4):1275-81. doi: 10.1097/CCM.0b013e31819cedfd.
7
Volume replacement in critically ill patients with acute renal failure.急性肾衰竭危重症患者的容量补充
J Am Soc Nephrol. 2001 Feb;12 Suppl 17:S33-9.
8
[Fluid therapy--pathophysiological principles as well as intra- and perioperative monitoring].[液体疗法——病理生理原理以及围手术期监测]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2006 Jun;41(6):392-8; quiz 399. doi: 10.1055/s-2006-947307.
9
The colloid-crystalloid controversy.胶体与晶体之争。
Klin Wochenschr. 1991;69 Suppl 26:104-11.
10
[Volume expansion during septic shock].[感染性休克期间的容量扩张]
Bull Acad Natl Med. 2000;184(8):1621-9; discussion 1629-30.

引用本文的文献

1
Starch Wars-New Episodes of the Saga. Changes in Regulations on Hydroxyethyl Starch in the European Union.淀粉之战——传奇新篇章。欧盟羟乙基淀粉法规的变化
Front Vet Sci. 2019 Jan 18;5:336. doi: 10.3389/fvets.2018.00336. eCollection 2018.
2
Jugular vein distensibility, a noninvasive parameter of fluid responsiveness?颈静脉扩张性,一种液体反应性的非侵入性参数?
Rev Bras Ter Intensiva. 2015 Jul-Sep;27(3):190-2. doi: 10.5935/0103-507X.20150039.
3
Vasodilation increases pulse pressure variation, mimicking hypovolemic status in rabbits.血管舒张会增加脉压变异,使兔子出现低血容量状态的假象。
Clinics (Sao Paulo). 2010 Feb;65(2):189-94. doi: 10.1590/S1807-59322010000200011.

当代液体管理中的问题

Issues in contemporary fluid management.

作者信息

Vincent J L

机构信息

Université Libre de Bruxelles, Brussels, Belgium.

出版信息

Crit Care. 2000;4 Suppl 2(Suppl 2):S1-2. doi: 10.1186/cc964. Epub 2000 Oct 13.

DOI:10.1186/cc964
PMID:11255591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3226169/
Abstract

Fluid management strategies need to be guided by an understanding of the pathophysiologic mechanisms underlying fluid imbalance. In the hypovolaemic patient, reduced circulating blood volume and venous return and, in severe cases, altered tissue perfusion may initiate a cascade of pathophysiologic processes culminating in multiple organ failure. The objectives of fluid management are to maintain adequate blood pressure, tissue oxygenation and intravascular fluid volume. Both crystalloids and colloids can be useful for these purposes. In the hypovolaemic patient with normal pulmonary function, the use of colloids to maintain colloid osmotic pressure can limit the development of peripheral as well as pulmonary oedema. However, choice of fluid is less important in states of increased lung capillary permeability. Further evidence is needed to broaden understanding of the optimal roles for particular fluid management strategies. Experimental models can make an important contribution in gathering such evidence. Rigorous pharmacoeconomic studies are also needed to define the benefits and costs of differing fluid regimens.

摘要

液体管理策略需要以对液体失衡背后病理生理机制的理解为指导。在低血容量患者中,循环血容量和静脉回流减少,在严重情况下,组织灌注改变可能引发一系列病理生理过程,最终导致多器官功能衰竭。液体管理的目标是维持足够的血压、组织氧合和血管内容量。晶体液和胶体液都可用于这些目的。在肺功能正常的低血容量患者中,使用胶体液维持胶体渗透压可限制外周及肺水肿的发展。然而,在肺毛细血管通透性增加的状态下,液体的选择不那么重要。需要进一步的证据来拓宽对特定液体管理策略最佳作用的理解。实验模型可在收集此类证据方面做出重要贡献。还需要进行严格的药物经济学研究,以确定不同液体方案的益处和成本。